Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Advanced Corneal System seeks Vitrase approval in Mexico

June 4, 1998

New topical corticosteroid available in U.S. for ophthalmic use

June 1, 1998

Topical NGF demonstrates efficacy in the treatment of corneal ulcers

May 21, 1998

Alcon's diclofenac sodium approved for ocular inflammation indication

May 20, 1998

Another market introduction for Xalatan

May 18, 1998

Verteporfin proven safe in phase III trials

May 15, 1998

Vitrase shown to clear vitreous hemorrhage

May 15, 1998

Akorn launches generic cromolyn sodium

May 12, 1998

VISX Excimer Laser System approved in Japan

May 11, 1998

Novo Nordisk discovers potent sst4 receptor agonist

May 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...